MedTrace Logo

mulTiplex Immunoassay qualiTy assuRance Panel

NCT07562061 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2026-05-01

No results posted yet for this study

Summary

Collection of serum from women not living with HIV, who received the GBS6 vaccine in the "a placebo-controlled clinical trial investigating the safety and immunogenicity of GBS6 in pregnant women with and without human immunodeficiency virus (HIV) infection and their infants" (GBS6) Clinical Trial in Kampala, Uganda, for the Development of Group B Streptococcus quality assurance panel for the GASTON multiplex anti-CPS IgG immunoassay

Conditions

  • Group B Strep Infection

Interventions

OTHER

Collection of 50mls of blood

50mls of blood will be collected from all participants who give consent.

Sponsors & Collaborators

  • St George's, University of London

    lead OTHER

Principal Investigators

  • Kirsty Le Doare · City St George's, University of London

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-27
Primary Completion
2026-05-31
Completion
2027-01-31

Countries

  • Uganda

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07562061 on ClinicalTrials.gov